NEO1 and neuroblastoma: To determine the contribution of NEO1 in NB progression, we first evaluated its expression in NB patients (n = 21) by immunohistochemistry on paraffin-embedded samples, categorized according to INRGSS (International Neuroblastoma Risk Group staging system) [24].